Q3 Earnings Forecast for Curaleaf Issued By Seaport Res Ptn

Key Points

• Seaport Res Ptn has revised Curaleaf's Q3 2025 EPS estimate to (-$0.08), down from a previous estimate of (-$0.07), reflecting concerns about the company's profitability.
• Curaleaf recently reported Q2 earnings of (-$0.06) per share, beating analysts' expectations of (-$0.07).
• Cormark upgraded Curaleaf's stock rating from "hold" to "moderate buy", indicating growing optimism despite the adjusted earnings forecast.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Free Report) - Equities research analysts at Seaport Res Ptn cut their Q3 2025 earnings per share estimates for shares of Curaleaf in a report released on Monday, August 11th. Seaport Res Ptn analyst S. Randhawa now anticipates that the company will post earnings per share of ($0.08) for the quarter, down from their prior estimate of ($0.07). The consensus estimate for Curaleaf's current full-year earnings is ($0.25) per share. Seaport Res Ptn also issued estimates for Curaleaf's Q4 2025 earnings at ($0.08) EPS.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%.

Separately, Cormark raised shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a research report on Friday, August 8th.

Curaleaf Stock Performance

Shares of CURLF traded down $0.28 during trading hours on Wednesday, hitting $2.66. The stock had a trading volume of 1,762,433 shares, compared to its average volume of 1,728,826. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.70 and a current ratio of 1.47. The firm has a 50-day moving average price of $1.27 and a 200 day moving average price of $1.11. Curaleaf has a fifty-two week low of $0.68 and a fifty-two week high of $3.58. The firm has a market capitalization of $1.78 billion, a price-to-earnings ratio of -8.31 and a beta of 0.69.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.